Handok Pharm enjoys brisk sales in three quarters

Published: 2003-11-19 06:58:00

Updated: 2003-11-19 06:58:00

Handok Pharm said it reaped 161.3 billion won for nine months of this year thanks to brisk sales of Amaryl (41.6 billion won vs. 30.5 billion won from a year earlier) and Tritace (18.0 billion won vs. 13.0 billion won from a year earlier). The net profit recorded 13.7 billion won.

The company'...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK